新的移变异扩展了IRF2BP2中的遗传缺陷的地图
José María García-Aznar1, Emilia Maneiro Pampín1, Maite García Ramos1
1Department of Immunology, Health in Code, A Coruña, Galicia, Spain.
Frontiers in immunology
|October 25, 2023
概括
在IRF2BP2中发现了五种新的突变,导致一次性免疫缺陷,特别是常见变量免疫缺陷 (CVID). 这些遗传发现扩大了我们对IRF2BP2相关疾病及其各种临床表现的理解.
科学领域:
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 关于IRF2BP2突变引起疾病的知识有限.
- IRF2BP2哈普隆缺陷与常见可变免疫缺陷 (CVID) 有关.
- 截断IRF2BP2的变种最近定义了一个CVID的表型,具有胃肠道和自身免疫问题.
研究的目的:
- 为了确定与原发性免疫缺陷相关的IRF2BP2中的新突变.
- 描述IRF2BP2相关疾病的临床和遗传谱.
主要方法:
- 使用高通量测序分析了疑似原发性免疫缺陷的五个指数病例.
- 一个包括IRF2BP2在内的基因小组被用于基因测试.
- 进行了单核酸变异 (SNV),插入/删除 (indels) 和副本数变异 (CNV) 的查.
主要成果:
- 在IRF2BP2中发现了五种新的功能丧失 (LoF) 突变.
- 确定的变体包括移变化和包含IRF2BP2.2的大规模删除.
- 观察到的表型包括CVID,炎症性胃肠道特征和对病毒感染的倾向.
- 发现了新的和主导的遗传模式,以及不完全的透性.
结论:
- IRF2BP2的新型变异与原发性免疫缺陷有关,主要是CVID.
- 在IRF2BP2中首次报告了导致CVID的大型CNV.
- 需要进一步研究以了解IRF2BP2调节机制及其在疾病变异性中的作用.
相关概念视频
Translation
14.9K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.9K
Point and Frameshift Mutations
19
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
19
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
RNA Splicing
56.4K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.4K
Mismatch Repair
4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K


